362 related articles for article (PubMed ID: 28132922)
1. Clinical Features, Surgical Treatment, and Long-Term Outcome in Elderly Patients with Moyamoya Disease.
Ge P; Zhang Q; Ye X; Liu X; Deng X; Wang R; Zhang Y; Zhang D; Zhao J
World Neurosurg; 2017 Apr; 100():459-466. PubMed ID: 28132922
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Outcome After Conservative Treatment and Direct Bypass Surgery of Moyamoya Disease at Late Suzuki Stage.
Ge P; Zhang Q; Ye X; Liu X; Deng X; Li H; Wang R; Zhang Y; Zhang D; Zhao J
World Neurosurg; 2017 Jul; 103():283-290. PubMed ID: 28366750
[TBL] [Abstract][Full Text] [Related]
4. Clinical Features, Surgical Treatment, and Long-Term Outcome in Children with Hemorrhagic Moyamoya Disease.
Ge P; Zhang Q; Ye X; Wang S; Zhang D; Zhao J
J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1517-1523. PubMed ID: 29567119
[TBL] [Abstract][Full Text] [Related]
5. Clinical Features and Long-Term Outcomes of Unilateral Moyamoya Disease.
Zhang Q; Wang R; Liu Y; Zhang Y; Wang S; Cao Y; Zhao Y; Liu X; Wang J; Deng X; Gao F; Yang Z; Zhao M; Ge P; Ma Y; Zhao J; Zhang D
World Neurosurg; 2016 Dec; 96():474-482. PubMed ID: 27647029
[TBL] [Abstract][Full Text] [Related]
6. Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.
Bao XY; Duan L; Li DS; Yang WZ; Sun WJ; Zhang ZS; Zong R; Han C
Cerebrovasc Dis; 2012; 34(4):305-13. PubMed ID: 23146868
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors Associated with Neurologic Deterioration After Combined Direct and Indirect Revascularization in Patients with Moyamoya Disease on the East Coast of China.
Zhai X; Mao L; Wang H; Zhang X; Hang C; Wu W; Jia Y; Liu L
World Neurosurg; 2018 Oct; 118():e92-e98. PubMed ID: 29945005
[TBL] [Abstract][Full Text] [Related]
8. Encephaloduroarteriosynangiosis for hemorrhagic moyamoya disease: long-term outcome of a consecutive series of 95 adult patients from a single center.
Wang QN; Bao XY; Zhang Y; Zhang Q; Li DS; Duan L
J Neurosurg; 2019 Jun; 130(6):1898-1905. PubMed ID: 29999465
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors for Newly Developed Cerebral Infarction After Surgical Revascularization for Adults with Moyamoya Disease.
Park W; Ahn JS; Lee HS; Park JC; Kwun BD
World Neurosurg; 2016 Aug; 92():65-73. PubMed ID: 27020972
[TBL] [Abstract][Full Text] [Related]
10. Encephaloduroarteriosynangiosis for pediatric moyamoya disease: long-term follow-up of 100 cases at a single center.
Zhang Y; Bao XY; Duan L; Yang WZ; Li DS; Zhang ZS; Han C; Zhao F; Zhang Q; Wang QN
J Neurosurg Pediatr; 2018 Aug; 22(2):173-180. PubMed ID: 29856299
[TBL] [Abstract][Full Text] [Related]
11. dl-3-n-butylphthalide for alleviation of neurological deficit after combined extracranial-intracranial revascularization for moyamoya disease: a propensity score-matched analysis.
Li Z; Lu J; Ma L; Wu C; Xu Z; Chen X; Ye X; Wang R; Zhao Y
J Neurosurg; 2019 Feb; 132(2):421-433. PubMed ID: 30771781
[TBL] [Abstract][Full Text] [Related]
12. Combined STA-MCA Bypass and Encephalodurosynangiosis Versus Encephalodurosynangiosis Alone in Adult Hemorrhagic Moyamoya Disease: A 5 -Year Outcome Study.
Zhang M; Raynald ; Zhang D; Liu X; Wang R; Zhang Y; Zhao J
J Stroke Cerebrovasc Dis; 2020 Jun; 29(6):104811. PubMed ID: 32312630
[TBL] [Abstract][Full Text] [Related]
13. Grading of moyamoya disease allows stratification for postoperative ischemia in bilateral revascularization surgery.
Czabanka M; Boschi A; Acker G; Peña-Tapia P; Schubert GA; Schmiedek P; Vajkoczy P
Acta Neurochir (Wien); 2016 Oct; 158(10):1895-900. PubMed ID: 27573349
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up results in 142 adult patients with moyamoya disease according to management modality.
Lee SB; Kim DS; Huh PW; Yoo DS; Lee TG; Cho KS
Acta Neurochir (Wien); 2012 Jul; 154(7):1179-87. PubMed ID: 22476796
[TBL] [Abstract][Full Text] [Related]
15. Encephaloduroateriosynangiosis versus conservative treatment for patients with moyamoya disease at late Suzuki stage.
Ge P; Ye X; Zhang Q; Zhang D; Wang S; Zhao J
J Clin Neurosci; 2018 Apr; 50():277-280. PubMed ID: 29366619
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes after conservative and EDAS treatment for 111 elderly patients with moyamoya disease: longitudinal and cross-sectional study.
Li JJ; Wang XP; Wang QN; Bao XY; Guo QB; Kong ZQ; Gao G; Wang MJ; Liu SM; Fu HG; Zhang Q; Duan L
J Neurosurg; 2024 Mar; 140(3):800-808. PubMed ID: 37724788
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Outcomes After Combined Revascularization Surgery in Adult Hemorrhagic Moyamoya Disease.
Jiang H; Yang H; Ni W; Lei Y; Su J; Gu Y; Xu B; Mao Y
World Neurosurg; 2018 Aug; 116():e1032-e1041. PubMed ID: 29859362
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and outcomes in 154 patients with haemorrhagic moyamoya disease: comparison of conservative treatment and surgical revascularization.
Huang Z; Ding X; Men W; Zhang D; Zhao Y; Wang R; Wang S; Zhao J
Neurol Res; 2015 Oct; 37(10):886-92. PubMed ID: 26159234
[TBL] [Abstract][Full Text] [Related]
19. Outcome in adult patients with hemorrhagic moyamoya disease after combined extracranial-intracranial bypass.
Jiang H; Ni W; Xu B; Lei Y; Tian Y; Xu F; Gu Y; Mao Y
J Neurosurg; 2014 Nov; 121(5):1048-55. PubMed ID: 25127415
[TBL] [Abstract][Full Text] [Related]
20. Surgical outcomes following encephaloduroarteriosynangiosis in adult moyamoya disease associated with Type 2 diabetes.
Ren B; Zhang ZS; Liu WW; Bao XY; Li DS; Han C; Xian P; Zhao F; Wang H; Wang H; Duan L
J Neurosurg; 2016 Aug; 125(2):308-14. PubMed ID: 26745491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
